Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 21,887Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 22IPSEN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 9717724

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-2091

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-12

blank

02

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 9492442

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1917

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-12

blank

03

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 9364473

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1856

Delist Requested :

Patent Use Description : TREATMENT OF METASTATI...

Patent Expiration Date : 2033-06-12

blank

04

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 8703181

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1434

Delist Requested :

Patent Use Description : TREATMENT OF PANCREATI...

Patent Expiration Date : 2025-05-02

blank

05

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 11369597

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1848

Delist Requested :

Patent Use Description : TREATMENT OF METASTATI...

Patent Expiration Date : 2033-06-12

blank

06

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 9339497

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1848

Delist Requested :

Patent Use Description : TREATMENT OF METASTATI...

Patent Expiration Date : 2033-06-12

blank

07

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 9452162

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1899

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-12

blank

08

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 9492442

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1899

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-12

blank

09

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 9717724

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1848

Delist Requested :

Patent Use Description : TREATMENT OF METASTATI...

Patent Expiration Date : 2033-06-12

blank

10

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

IRINOTECAN HYDROCHLORIDE

US Patent Number : 9492442

Drug Substance Claim :

Drug Product Claim :

Application Number : 207793

Patent Use Code : U-1848

Delist Requested :

Patent Use Description : TREATMENT OF METASTATI...

Patent Expiration Date : 2033-06-12

blank